← Browse by Condition
Medical Condition
actinic keratoses
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for actinic keratoses sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
NCT06499415 Phase 4
Recruiting
Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
Enrollment
232 pts
Location
Netherlands
Sponsor
Maastricht University Medical ...
NCT06428721
Recruiting
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
Enrollment
80 pts
Location
United States
Sponsor
Wright State University
NCT06385340
Recruiting
Investigation of the Effect of Lipikar Baume AP+M
Enrollment
20 pts
Location
Germany
Sponsor
CentroDerm GmbH
NCT03906253
Recruiting
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
Enrollment
72 pts
Location
United States
Sponsor
Wright State University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology